Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 471 All time
- Disclosed funding
- $19.1B 398 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| CT Caldera TherapeuticsCompany profile Develops bispecific antibody CLD-423 for inflammatory bowel disease Develops bispecific antibody CLD-423 for inflammatory bowel disease | $37.5M | Series A1Series A | Biotech | United States | Investors | |
| RL Develops AI operating system for oncology workflows | $11.1M | Series A | Biotech, AI | United States | Investors | |
| AB Provider of human induced pluripotent stem cell (iPSC) technologies | $2.8M | Undisclosed | Biotech | United Kingdom | Investors | |
| VO Vivere OncotherapiesCompany profile Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells. Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells. | $10M | Series A | Biotech | United States | Investors | |
| N NucleraCompany profile Provides rapid access to functional proteins through benchtop eProtein Discovery System Provides rapid access to functional proteins through benchtop eProtein Discovery System | $12M | Series C+ | Biotech | United Kingdom | Investors | |
| S Provides enterprise informatics platform for laboratories | Undisclosed | Undisclosed | Biotech, Enterprise software | United States | Investors | |
| CB AI platform for accelerated drug discovery and development | $25M | Series A | Biotech, AI | United States | Investors | |
| P Develops AI-driven drug discovery for proximity therapeutics | $80M | Undisclosed | Biotech | United States | Investors | |
| AB Avenue BiosciencesCompany profile Develops high-throughput protein engineering technology for biologics manufacturing Develops high-throughput protein engineering technology for biologics manufacturing | $5.7M | Seed+Seed | Biotech | United States | Investors | |
| F FluoSpheraCompany profile Develops human-based preclinical platform for drug safety and efficacy testing Develops human-based preclinical platform for drug safety and efficacy testing | €1.2M | Undisclosed | Biotech | Switzerland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.